AVCT — Avacta Share News
0.000.00%
Last trade - 00:00- £279.66m
- £287.42m
- £0.11m
REG - Avacta Group PLC - Second dose escalation in phase 1 trial of AVA6000
AnnouncementREG - Avacta Group PLC - Price Monitoring Extension
AnnouncementREG - Avacta Group PLC - Second Price Monitoring Extn
AnnouncementREG - Avacta Group PLC - Result of Annual General Meeting
AnnouncementREG - Avacta Group PLC - Price Monitoring Extension
AnnouncementREG - Avacta Group PLC - Second Price Monitoring Extn
AnnouncementREG - Avacta Group PLC - Posting of Annual Report and Notice of AGM
AnnouncementREG - Avacta Group PLC - AffyXell expands partnership with GenScript ProBio
AnnouncementRCS - Avacta Group PLC - London Therapeutics headquarters established
AnnouncementREG - Avacta Group PLC - Block Listing Application to AIM (update)
AnnouncementREG - Avacta Group PLC - Block Listing Application to AIM
AnnouncementREG - Avacta Group PLC - Issue of Equity and Total Voting Rights
AnnouncementREG - Avacta Group PLC - Issue of Equity and Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 13/04/2022
AnnouncementREG - Avacta Group PLC - AffyXell milestone and increased equity stake
AnnouncementREG - Avacta Group PLC - Poster presented at the AACR available to download
AnnouncementREG - Avacta Group PLC - Price Monitoring Extension
AnnouncementREG - Avacta Group PLC - Second Price Monitoring Extn
AnnouncementREG - Avacta Group PLC - Price Monitoring Extension
Announcement